Diversity and disease pathogenesis in mycobacterium tuberculosis

Trends in Microbiology

Volumn 23, Issue 1, 2015, Pages 14-21

  Warner, Digby F ^a   Koch, Anastasia ^a   Mizrahi, Valerie ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Drugs; Epistasis; Evolution; Genomics; Mutagenesis; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; DISEASE COURSE; GENE LOCUS; GENETIC VARIABILITY; GENOME; GENOMICS; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; MICROENVIRONMENT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; TUBERCULOSIS; GENETIC ASSOCIATION; GENETICS; MICROBIOLOGY; PATHOGENICITY; SYSTEMS BIOLOGY;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

GENETIC ASSOCIATION STUDIES; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SYSTEMS BIOLOGY; TUBERCULOSIS;

EID: 84920510674     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.10.005     Document Type: Review

References (79)

1. Zumla A., et al. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet 2013, 382:1765-1767.
2. Zumla A., et al. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 2013, 12:388-404.
3. Weiner J., Kaufmann S.H. Recent advances towards tuberculosis control: vaccines and biomarkers. J. Intern. Med. 2014, 275:467-480.
4. Galagan J.E. Genomic insights into tuberculosis. Nat. Rev. Genet. 2014, 15:307-320.
5. McAdam P.R., et al. High-throughput sequencing for the study of bacterial pathogen biology. Curr. Opin. Microbiol. 2014, 19C:106-113.
6. McPherson J.D. A defining decade in DNA sequencing. Nat. Methods 2014, 11:1003-1005.
7. Gagneux S. Genetic diversity in Mycobacterium tuberculosis. Curr. Top. Microbiol. Immunol. 2013, 374:1-25.
8. Comas I., et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. Genet. 2013, 45:1176-1182.
9. Supply P., et al. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat. Genet. 2013, 45:172-179.
10. Achtman M. Insights from genomic comparisons of genetically monomorphic bacterial pathogens. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:860-867.
11. Stucki D., Gagneux S. Single nucleotide polymorphisms in Mycobacterium tuberculosis and the need for a curated database. Tuberculosis 2013, 93:30-39.
12. Hershberg R., et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 2008, 6:e311.
13. Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:850-859.
14. Bryant J.M., et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir. Med. 2013, 1:786-792.
15. Casali N., et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 2014, 46:279-286.
16. Walker T.M., et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 2013, 13:137-146.
17. Robertson B.D., et al. Detection and treatment of subclinical tuberculosis. Tuberculosis 2012, 92:447-452.
18. Bos K.I., et al. Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis. Nature 2014, 514:494-497.
19. Boritsch E.C., et al. A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent. Mol. Microbiol. 2014, 93:835-852.
20. Namouchi A., et al. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res. 2012, 22:721-734.
21. Stinear T.P., et al. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1345-1349.
22. Koser C.U., et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 2013, 369:290-292.
23. Sun G., et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J. Infect. Dis. 2012, 206:1724-1733.
24. Perez-Lago L., et al. Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J. Infect. Dis. 2014, 209:98-108.
25. Merker M., et al. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS ONE 2013, 8:e82551.
26. Hanekom M., et al. Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent. PLoS ONE 2013, 8:e70178.
27. Wood R., et al. Tuberculosis control has failed in South Africa: time to reappraise strategy. S. Afr. Med. J. 2011, 101:111-114.
28. Kaplan G., et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 2003, 71:7099-7108.
29. Saunders N.J., et al. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J. Infect. 2011, 62:212-217.
30. McGrath M., et al. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2014, 69:292-302.
31. Domenech P., et al. The origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulence. Infect. Immun. 2014, 82:2902-2912.
32. Koch A., et al. The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?. Emerg. Microb. Infect. 2014, 3:e17.
33. O'Garra A., et al. The immune response in tuberculosis. Annu. Rev. Immunol. 2013, 31:475-527.
34. Lin P.L., et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 2014, 20:75-79.
35. Farhat M.R., et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat. Genet. 2013, 45:1183-1189.
36. Zhang H., et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat. Genet. 2013, 45:1255-1260.
37. Blower S.M., Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat. Med. 2004, 10:1111-1116.
38. Heaton B.E., et al. Deficiency of double-strand DNA break repair does not impair Mycobacterium tuberculosis virulence in multiple animal models of infection. Infect. Immun. 2014, 82:3177-3185.
39. Comas I., et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 2012, 44:106-110.
40. Dos Vultos T., et al. Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS ONE 2008, 3:e1538.
41. Comas I., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 2010, 42:498-503.
42. Copin R., et al. Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition. MBio 2014, 5. e00960-13.
43. Homolka S., et al. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog. 2010, 6:e1000988.
44. Portevin D., et al. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011, 7:e1001307.
45. Krishnan N., et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS ONE 2011, 6:e23870.
46. Reiling N., et al. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. MBio 2013, 4. e00250-13.
47. Parish T., et al. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 2003, 71:1134-1140.
48. Warner D.F. Mycobacterium tuberculosis metabolism. Cold Spring Harb. Perspect. Med. 2014, Published online November 2014. 10.1101/cshperspect.a021121.
49. Fenner L., et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet. 2013, 9:e1003318.
50. Brites D., Gagneux S. Old and new selective pressures on Mycobacterium tuberculosis. Infect. Genet. Evol. 2012, 12:678-685.
51. Middelkoop K., et al. Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community. Int. J. Epidemiol. 2014, 43:1114-1122.
52. Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathog. 2009, 5:e1000600.
53. Gonzalo-Asensio J., et al. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:11491-11496.
54. Russell D.G. The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant. Curr. Opin. Microbiol. 2013, 16:78-84.
55. Middelkoop K., et al. Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. J. Infect. Dis. 2014, Published online July 22, 2014. 10.1093/infdis/jiu403.
56. Niemann S., Supply P. Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches. Cold Spring Harb. Perspect. Med. 2014, Published online September 4, 2014. 10.1101/cshperspect.a021188.
57. Ford C.B., et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 2011, 43:482-486.
58. Colangeli R., et al. Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. PLoS ONE 2014, 9:e91024.
59. Yang Z., et al. How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology. Infect. Genet. Evol. 2011, 11:1164-1167.
60. Gill W.P., et al. A replication clock for Mycobacterium tuberculosis. Nat. Med. 2009, 15:211-214.
61. Via L.E., et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 2008, 76:2333-2340.
62. Barry C.E., et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 2009, 7:845-855.
63. Colijn C., et al. Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PLoS ONE 2011, 6:e18327.
64. Ford C.B., et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 2013, 45:784-790.
65. McGuire A.M., et al. Comparative analysis of mycobacterium and related actinomycetes yields insight into the evolution of Mycobacterium tuberculosis pathogenesis. BMC Genomics 2012, 13:120.
66. Baker J.J., et al. Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources. Mol. Microbiol. 2014, 94:56-69.
67. Abramovitch R.B., et al. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol. Microbiol. 2011, 80:678-694.
68. Tsolaki A.G., et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4865-4870.
69. Golby P., et al. Genome-level analyses of Mycobacterium bovis lineages reveal the role of SNPs and antisense transcription in differential gene expression. BMC Genomics 2013, 14:710.
70. Rose G., et al. Mapping of genotype-phenotype diversity among clinical isolates of Mycobacterium tuberculosis by sequence-based transcriptional profiling. Genome Biol. Evol. 2013, 5:1849-1862.
71. Safi H., et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-b-D-arabinose biosynthetic and utilization pathway genes. Nat. Genet. 2013, 45:1190-1197.
72. Nebenzahl-Guimaraes H., et al. Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2014, 69:331-342.
73. Wakamoto Y., et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 2013, 339:91-95.
74. Shell S.S., et al. DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS Pathog. 2013, 9:e1003419.
75. Fang G., et al. Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing. Nat. Biotechnol. 2012, 30:1232-1239.
76. Doughty E.L., et al. Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer. PeerJ 2014, 2:e585.
77. Gagneux S., Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 2007, 7:328-337.
78. du Preez I., Loots D.T. New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa. Tuberculosis 2013, 93:330-337.
79. Nasstrom E., et al. Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever. Elife 2014, e03100.